| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYD88 MYO1A ABCA13 MYO19 NVL RNF213 ATP9B ARID1A KIF20B DNAH1 BLM MCM9 SMARCA2 SMARCA4 DNA2 HSPA14 | 4.10e-06 | 614 | 135 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | TRAF2 TRAF6 UBR4 MKRN2 HECTD4 RNF213 ZZEF1 TRIM24 BRAP ZNF451 ARIH1 HERC1 TRIM38 FBXW11 | 9.94e-06 | 512 | 135 | 14 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | TRAF2 TRAF6 UBR4 MKRN2 HECTD4 RNF213 ZZEF1 TRIM24 BRAP ZNF451 ARIH1 HERC1 TRIM38 FBXW11 | 1.53e-05 | 532 | 135 | 14 | GO:0016755 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.51e-05 | 127 | 135 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | acyltransferase activity | TRAF2 TRAF6 UBR4 MKRN2 HECTD4 RNF213 CHAT ZZEF1 TRIM24 BRAP ZDHHC23 ZNF451 ARIH1 HERC1 TRIM38 FBXW11 | 7.06e-05 | 775 | 135 | 16 | GO:0016746 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.45e-05 | 262 | 135 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | TRAF6 UBR4 MKRN2 RNF213 ZZEF1 TRIM24 BRAP ZNF451 ARIH1 TRIM38 FBXW11 | 8.44e-05 | 398 | 135 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | TRAF2 TRAF6 UBR4 MKRN2 HECTD4 RNF213 TRIM24 BRAP ARIH1 HERC1 TRIM38 FBXW11 | 9.02e-05 | 473 | 135 | 12 | GO:0004842 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.11e-04 | 37 | 135 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 MYO19 NVL RNF213 ATP9B KIF20B BLM MCM9 SMARCA4 DNA2 HSPA14 | 2.07e-04 | 441 | 135 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 9.78e-04 | 372 | 135 | 9 | GO:0061630 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.07e-03 | 30 | 135 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.18e-03 | 31 | 135 | 3 | GO:0140033 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP53 USP34 TRAF2 TRAF6 GNL3L PARP8 UVSSA UBR4 MKRN2 HECTD4 RNF213 PARP14 ZZEF1 TRIM24 BRAP ATG4B ASB9 ZNF451 USP4 ARIH1 HERC1 FBXL2 TRIM38 FBXW11 | 1.02e-07 | 1074 | 134 | 24 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP53 USP34 TRAF2 TRAF6 GNL3L UVSSA UBR4 MKRN2 HECTD4 RNF213 ZZEF1 TRIM24 BRAP ASB9 ZNF451 USP4 ARIH1 HERC1 FBXL2 TRIM38 FBXW11 | 2.21e-06 | 1009 | 134 | 21 | GO:0070647 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRAF2 TRAF6 GNL3L UVSSA UBR4 MKRN2 HECTD4 RNF213 ZZEF1 TRIM24 BRAP ASB9 ZNF451 USP4 ARIH1 HERC1 FBXL2 TRIM38 FBXW11 | 5.19e-06 | 893 | 134 | 19 | GO:0032446 |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRAF2 TRAF6 GNL3L UVSSA UBR4 MKRN2 HECTD4 RNF213 ZZEF1 TRIM24 BRAP ASB9 USP4 ARIH1 HERC1 FBXL2 TRIM38 FBXW11 | 5.29e-06 | 811 | 134 | 18 | GO:0016567 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 4.58e-05 | 145 | 134 | 7 | GO:0001578 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 RTTN RANBP9 SPACA9 PRC1 AK7 SPDL1 DNAH1 CEP350 DNAAF5 ZPR1 CEP295 STAG2 CFAP46 FBXW11 | 7.00e-05 | 720 | 134 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | interleukin-17-mediated signaling pathway | 7.31e-05 | 13 | 134 | 3 | GO:0097400 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 7.87e-05 | 109 | 134 | 6 | GO:0035082 | |
| GeneOntologyCellularComponent | bBAF complex | 2.86e-05 | 10 | 132 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 8.51e-05 | 14 | 132 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | gamma DNA polymerase complex | 1.18e-04 | 3 | 132 | 2 | GO:0005760 | |
| GeneOntologyCellularComponent | nBAF complex | 1.30e-04 | 16 | 132 | 3 | GO:0071565 | |
| Domain | ARM-type_fold | USP34 IPO7 UBR4 RTTN NCBP1 ARID1A DNAAF5 IFRD1 UNC45B IFRD2 PUM1 STAG2 | 5.66e-06 | 339 | 133 | 12 | IPR016024 |
| Domain | Gln-Leu-Gln_QLQ | 5.03e-05 | 2 | 133 | 2 | IPR014978 | |
| Domain | IFRD_C | 5.03e-05 | 2 | 133 | 2 | PF04836 | |
| Domain | SnAC | 5.03e-05 | 2 | 133 | 2 | PF14619 | |
| Domain | QLQ | 5.03e-05 | 2 | 133 | 2 | SM00951 | |
| Domain | QLQ | 5.03e-05 | 2 | 133 | 2 | PS51666 | |
| Domain | IFRD | 5.03e-05 | 2 | 133 | 2 | PF05004 | |
| Domain | Interferon-rel_develop_reg_C | 5.03e-05 | 2 | 133 | 2 | IPR006921 | |
| Domain | SnAC | 5.03e-05 | 2 | 133 | 2 | SM01314 | |
| Domain | SnAC | 5.03e-05 | 2 | 133 | 2 | IPR029295 | |
| Domain | QLQ | 5.03e-05 | 2 | 133 | 2 | PF08880 | |
| Domain | Interferon-rel_develop_reg_N | 5.03e-05 | 2 | 133 | 2 | IPR007701 | |
| Domain | ARM-like | 1.38e-04 | 270 | 133 | 9 | IPR011989 | |
| Domain | DNA_pol_A | 1.50e-04 | 3 | 133 | 2 | PF00476 | |
| Domain | DNA-dir_DNA_pol_A_palm_dom | 1.50e-04 | 3 | 133 | 2 | IPR001098 | |
| Domain | DNA_POLYMERASE_A | 1.50e-04 | 3 | 133 | 2 | PS00447 | |
| Domain | POLAc | 1.50e-04 | 3 | 133 | 2 | SM00482 | |
| Domain | - | 1.93e-04 | 222 | 133 | 8 | 1.25.10.10 | |
| Domain | HSA | 2.99e-04 | 4 | 133 | 2 | SM00573 | |
| Domain | HSA | 2.99e-04 | 4 | 133 | 2 | PS51204 | |
| Domain | HSA_dom | 2.99e-04 | 4 | 133 | 2 | IPR014012 | |
| Domain | HSA | 2.99e-04 | 4 | 133 | 2 | PF07529 | |
| Domain | P-loop_NTPase | GNL3L MYO1A ABCA13 MYO19 NVL RNF213 CMSS1 AK7 KIF20B DNAH1 BLM MTHFD1 MCM9 SMARCA2 SMARCA4 DNA2 | 3.52e-04 | 848 | 133 | 16 | IPR027417 |
| Domain | BRK | 7.41e-04 | 6 | 133 | 2 | SM00592 | |
| Domain | RIH_assoc-dom | 7.41e-04 | 6 | 133 | 2 | IPR013662 | |
| Domain | CLTH | 7.41e-04 | 6 | 133 | 2 | PF10607 | |
| Domain | CRA | 7.41e-04 | 6 | 133 | 2 | SM00757 | |
| Domain | CTLH/CRA | 7.41e-04 | 6 | 133 | 2 | IPR024964 | |
| Domain | BRK_domain | 7.41e-04 | 6 | 133 | 2 | IPR006576 | |
| Domain | Ins145_P3_rec | 7.41e-04 | 6 | 133 | 2 | PF08709 | |
| Domain | TNF_rcpt--assoc_TRAF | 7.41e-04 | 6 | 133 | 2 | IPR012227 | |
| Domain | RIH_assoc | 7.41e-04 | 6 | 133 | 2 | PF08454 | |
| Domain | RIH_dom | 7.41e-04 | 6 | 133 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.41e-04 | 6 | 133 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.41e-04 | 6 | 133 | 2 | IPR015925 | |
| Domain | - | 7.41e-04 | 6 | 133 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.41e-04 | 6 | 133 | 2 | PF01365 | |
| Domain | Liprin | 7.41e-04 | 6 | 133 | 2 | IPR029515 | |
| Domain | CRA_dom | 7.41e-04 | 6 | 133 | 2 | IPR013144 | |
| Domain | BRK | 7.41e-04 | 6 | 133 | 2 | PF07533 | |
| Domain | Bromodomain_CS | 8.14e-04 | 26 | 133 | 3 | IPR018359 | |
| Domain | - | GNL3L ABCA13 MYO19 NVL RNF213 CMSS1 AK7 DNAH1 BLM MTHFD1 MCM9 SMARCA2 SMARCA4 DNA2 | 8.81e-04 | 746 | 133 | 14 | 3.40.50.300 |
| Domain | zf-C3HC4 | 1.10e-03 | 223 | 133 | 7 | PF00097 | |
| Domain | ZF_RING_2 | 1.34e-03 | 298 | 133 | 8 | PS50089 | |
| Domain | zf-TRAF | 1.37e-03 | 8 | 133 | 2 | PF02176 | |
| Domain | - | TRAF2 TRAF6 KDM5A MKRN2 RNF213 TRIM24 BRAP ARIH1 TRIM38 KDM4B | 1.42e-03 | 449 | 133 | 10 | 3.30.40.10 |
| Domain | JMJC | 1.51e-03 | 32 | 133 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.51e-03 | 32 | 133 | 3 | IPR003347 | |
| Domain | RING | 1.55e-03 | 305 | 133 | 8 | SM00184 | |
| Domain | JmjC | 1.65e-03 | 33 | 133 | 3 | SM00558 | |
| Domain | Znf_RING/FYVE/PHD | TRAF2 TRAF6 KDM5A MKRN2 RNF213 TRIM24 BRAP ARIH1 TRIM38 KDM4B | 1.67e-03 | 459 | 133 | 10 | IPR013083 |
| Domain | LisH | 1.75e-03 | 9 | 133 | 2 | PF08513 | |
| Domain | CTLH | 1.75e-03 | 9 | 133 | 2 | SM00668 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | PF02815 | |
| Domain | JmjN | 2.18e-03 | 10 | 133 | 2 | SM00545 | |
| Domain | MIR_motif | 2.18e-03 | 10 | 133 | 2 | IPR016093 | |
| Domain | JmjN | 2.18e-03 | 10 | 133 | 2 | PF02375 | |
| Domain | CTLH_C | 2.18e-03 | 10 | 133 | 2 | IPR006595 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | PS50919 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | SM00472 | |
| Domain | JMJN | 2.18e-03 | 10 | 133 | 2 | PS51183 | |
| Domain | CTLH | 2.18e-03 | 10 | 133 | 2 | PS50897 | |
| Domain | JmjN | 2.18e-03 | 10 | 133 | 2 | IPR003349 | |
| Domain | BROMODOMAIN_1 | 2.30e-03 | 37 | 133 | 3 | PS00633 | |
| Domain | Znf_RING | 2.35e-03 | 326 | 133 | 8 | IPR001841 | |
| Domain | Bromodomain | 2.48e-03 | 38 | 133 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.09e-03 | 41 | 133 | 3 | PS50014 | |
| Domain | MATH | 3.17e-03 | 12 | 133 | 2 | PS50144 | |
| Domain | Znf_TRAF | 3.17e-03 | 12 | 133 | 2 | IPR001293 | |
| Domain | Peptidase_M28 | 3.17e-03 | 12 | 133 | 2 | PF04389 | |
| Domain | Peptidase_M28 | 3.17e-03 | 12 | 133 | 2 | IPR007484 | |
| Domain | MATH/TRAF_dom | 3.17e-03 | 12 | 133 | 2 | IPR002083 | |
| Domain | MATH | 3.17e-03 | 12 | 133 | 2 | SM00061 | |
| Domain | MATH | 3.17e-03 | 12 | 133 | 2 | PF00917 | |
| Domain | Bromodomain | 3.31e-03 | 42 | 133 | 3 | IPR001487 | |
| Domain | BROMO | 3.31e-03 | 42 | 133 | 3 | SM00297 | |
| Domain | - | 3.31e-03 | 42 | 133 | 3 | 1.20.920.10 | |
| Domain | SPRY | 3.47e-03 | 87 | 133 | 4 | SM00449 | |
| Domain | ZF_TRAF | 3.73e-03 | 13 | 133 | 2 | PS50145 | |
| Domain | FA | 3.73e-03 | 13 | 133 | 2 | PF08736 | |
| Domain | FERM-adjacent | 3.73e-03 | 13 | 133 | 2 | IPR014847 | |
| Domain | FA | 3.73e-03 | 13 | 133 | 2 | SM01195 | |
| Domain | - | 4.33e-03 | 14 | 133 | 2 | 2.60.210.10 | |
| Domain | SPRY | 4.57e-03 | 94 | 133 | 4 | PF00622 | |
| Domain | SPRY_dom | 4.57e-03 | 94 | 133 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 4.75e-03 | 95 | 133 | 4 | IPR001870 | |
| Domain | B302_SPRY | 4.75e-03 | 95 | 133 | 4 | PS50188 | |
| Domain | ConA-like_dom | 4.85e-03 | 219 | 133 | 6 | IPR013320 | |
| Domain | ZF_RING_1 | 4.87e-03 | 291 | 133 | 7 | PS00518 | |
| Domain | - | 4.97e-03 | 15 | 133 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 4.97e-03 | 15 | 133 | 2 | SM00501 | |
| Domain | ARID_dom | 4.97e-03 | 15 | 133 | 2 | IPR001606 | |
| Domain | ARID | 4.97e-03 | 15 | 133 | 2 | PS51011 | |
| Domain | ARID | 4.97e-03 | 15 | 133 | 2 | PF01388 | |
| Domain | FBOX | 6.05e-03 | 52 | 133 | 3 | SM00256 | |
| Domain | Znf_RING_CS | 6.25e-03 | 163 | 133 | 5 | IPR017907 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 6.38e-03 | 17 | 133 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 6.38e-03 | 17 | 133 | 2 | PS51059 | |
| Domain | PARP | 6.38e-03 | 17 | 133 | 2 | PF00644 | |
| Domain | - | 6.38e-03 | 17 | 133 | 2 | 3.90.228.10 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 POLG UBR4 RTTN HECTD4 LMNB2 NCLN ARID1A ZZEF1 LDLR RYR1 ITPR3 CELSR2 PLA2G4B IFRD2 LRRC56 STK40 HERC1 HAS3 SIPA1L2 PUM1 ABTB2 ARAP1 | 5.87e-11 | 1105 | 136 | 23 | 35748872 |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 4.06e-09 | 95 | 136 | 8 | 29643511 | |
| Pubmed | TRAF2 PLVAP IPO7 UBR4 PPFIA3 CMSS1 NCLN ARID1A INTS3 TRIM24 RYR1 ITPR3 CEP350 SMARCA2 CEP295 STAG2 | 4.67e-09 | 638 | 136 | 16 | 31182584 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 HSPBAP1 MYO19 UBR4 RNF213 PBX4 NCBP1 LMNB2 AGPS PPFIA3 PARP14 ZZEF1 RYR1 MTHFD1 CEP295 TNR FBXO34 | 5.06e-09 | 736 | 136 | 17 | 29676528 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 MYD88 GNL3L POLG UVSSA HECTD4 LAMA3 RNF213 ATP9B ARID1A INTS3 DNAH1 RLF DNAAF5 IFRD1 FARP1 SMARCA2 ARIH1 STAG2 KDM4B ARAP1 FRMD3 FBXW11 | 1.73e-08 | 1489 | 136 | 23 | 28611215 |
| Pubmed | 5.85e-08 | 3 | 136 | 3 | 22029577 | ||
| Pubmed | 5.85e-08 | 3 | 136 | 3 | 36464671 | ||
| Pubmed | GNL3L IPO7 UBR4 NVL RNF213 ERMP1 AGPS NCLN PEX11B PARP14 LDLR ITPR3 CEP350 MTHFD1 BUB1 SMARCA4 CORO7 HSPA14 STAG2 | 1.58e-07 | 1168 | 136 | 19 | 19946888 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GNL3L IPO7 UBR4 LMNB2 CMSS1 NCLN PEX11B ITPR3 DNAAF5 IFRD1 LRIG1 CORO7 PUM1 HSPA14 STAG2 CAPN15 CDK4 | 1.78e-07 | 942 | 136 | 17 | 31073040 |
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 33481850 | ||
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 31906887 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYO1A KDM5A UBR4 LMNB2 CMSS1 PRC1 INTS3 TRIM24 BLM IFRD1 SMARCA4 STK40 PUM1 HSPA14 STAG2 FBXW11 | 2.68e-07 | 857 | 136 | 16 | 25609649 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TRAF2 GNL3L IPO7 PMPCB MYO19 UBR4 RANBP9 LMNB2 AGPS CMSS1 ARID1A KIF20B BLM RLF ATG4B MTHFD1 SMARCA2 SMARCA4 CORO7 PUM1 | 3.32e-07 | 1353 | 136 | 20 | 29467282 |
| Pubmed | CCDC14 RABEP2 UBR4 HECTD4 NVL RNF213 BRAP ITPR3 ZNF451 USP4 HERC1 CAPN15 | 4.61e-07 | 481 | 136 | 12 | 28190767 | |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 12200431 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GNL3L IPO7 KDM5A NVL NCBP1 TRIM24 KIF20B BLM RLF ZNF451 SMARCA4 STAG2 KDM4B | 8.53e-07 | 608 | 136 | 13 | 36089195 |
| Pubmed | 9.43e-07 | 83 | 136 | 6 | 28794006 | ||
| Pubmed | TRAF2 GNL3L PMPCB ARID1A LDLR METAP1 MTHFD1 PLA2G4B DGKK SMARCA2 SMARCA4 USP4 ARIH1 CDK4 | 1.15e-06 | 730 | 136 | 14 | 34857952 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 16940996 | ||
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 22003152 | ||
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.16e-06 | 6 | 136 | 3 | 25081545 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 IPO7 PMPCB ANXA3 UBR4 RANBP9 NCLN ITPR3 DNAAF5 PTPRD WDR97 GID8 SIPA1L2 CORO7 ABTB2 FBXW11 | 1.44e-06 | 974 | 136 | 16 | 28675297 |
| Pubmed | USP34 TRAF2 GNL3L KDM5A RANBP9 RNF213 PPFIA3 ARID1A ZZEF1 TRIM24 LDLR SMARCA2 SMARCA4 CEP295 SIGLEC1 SIPA1L2 DNA2 | 1.83e-06 | 1116 | 136 | 17 | 31753913 | |
| Pubmed | USP34 IPO7 UBR4 NVL NCBP1 LMNB2 ARID1A ITPR3 BLM SMARCA2 SMARCA4 PUM1 STAG2 | 1.88e-06 | 653 | 136 | 13 | 22586326 | |
| Pubmed | TCEA1 USP34 IPO7 ANXA3 UBR4 NVL RNF213 NCBP1 LMNB2 PRC1 BLM ZNF451 SMARCA2 SMARCA4 ARIH1 STAG2 | 2.41e-06 | 1014 | 136 | 16 | 32416067 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 26986003 | ||
| Pubmed | CCDC14 RABEP2 IPO7 PMPCB RNF213 NCBP1 PPFIA3 ARID1A ITPR3 CEP350 BLM PTPRD FARP1 HERC1 PUM1 FBXW11 | 3.71e-06 | 1049 | 136 | 16 | 27880917 | |
| Pubmed | MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner. | 4.83e-06 | 9 | 136 | 3 | 29125880 | |
| Pubmed | Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes. | 4.83e-06 | 9 | 136 | 3 | 20449947 | |
| Pubmed | IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. | 4.83e-06 | 9 | 136 | 3 | 21813773 | |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 23453969 | ||
| Pubmed | USP34 GNL3L NVL RNF213 LMNB2 BRAP SPDL1 CEP350 ZNF451 SMARCA4 CEP295 CORO7 PUM1 | 6.55e-06 | 733 | 136 | 13 | 34672954 | |
| Pubmed | 6.79e-06 | 250 | 136 | 8 | 33536335 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 22851693 | ||
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 20676093 | ||
| Pubmed | UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination. | 6.88e-06 | 10 | 136 | 3 | 23381138 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 6.88e-06 | 10 | 136 | 3 | 23129809 | |
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 18378686 | ||
| Pubmed | USP53 USP34 UVSSA HECTD4 ERMP1 ZZEF1 METAP1 ATG4B DNA2 KDM4B ARAP1 | 8.00e-06 | 529 | 136 | 11 | 14621295 | |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 24434549 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 9.56e-06 | 262 | 136 | 8 | 36880596 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | HECTD4 NVL AGPS PRC1 ARID1A ITPR3 BLM SMARCA2 SMARCA4 THAP12 | 9.77e-06 | 440 | 136 | 10 | 34244565 |
| Pubmed | USP34 TRAF2 TRAF6 ZBTB38 KDM5A POLG UBR4 HECTD4 RANBP9 NCBP1 ARID1A CEP350 METAP1 PTPRD ZNF451 SMARCA4 FBXW11 | 1.17e-05 | 1285 | 136 | 17 | 35914814 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.22e-05 | 357 | 136 | 9 | 37059091 | |
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 32294408 | ||
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 24735611 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.25e-05 | 12 | 136 | 3 | 9624153 | |
| Pubmed | 1.25e-05 | 12 | 136 | 3 | 11734557 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | USP34 ANXA3 ERMP1 LMNB2 PEX11B ARID1A TRIM24 DNAAF5 SMARCA2 PUM1 | 1.35e-05 | 457 | 136 | 10 | 32344865 |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 8670841 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23163725 | ||
| Pubmed | Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. | 1.52e-05 | 2 | 136 | 2 | 23257360 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10406848 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.52e-05 | 2 | 136 | 2 | 23076393 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15576411 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15240517 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.52e-05 | 2 | 136 | 2 | 33027072 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.52e-05 | 2 | 136 | 2 | 23088494 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20333683 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.52e-05 | 2 | 136 | 2 | 30478150 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22851711 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28378753 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.52e-05 | 2 | 136 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.52e-05 | 2 | 136 | 2 | 19144648 | |
| Pubmed | Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase. | 1.52e-05 | 2 | 136 | 2 | 27617738 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11318604 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 25761602 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.52e-05 | 2 | 136 | 2 | 29391527 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37634210 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 8208605 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 1.52e-05 | 2 | 136 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 1.52e-05 | 2 | 136 | 2 | 12620226 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27039070 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29848589 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22323536 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20810930 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 1.52e-05 | 2 | 136 | 2 | 9603422 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 25304051 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34997313 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23276717 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27097303 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 1.52e-05 | 2 | 136 | 2 | 23963727 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 1.52e-05 | 2 | 136 | 2 | 31375262 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17075831 | ||
| Pubmed | Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. | 1.52e-05 | 2 | 136 | 2 | 17409436 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 31216032 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 1.52e-05 | 2 | 136 | 2 | 32855269 | |
| Pubmed | The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6. | 1.52e-05 | 2 | 136 | 2 | 21805090 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 1.52e-05 | 2 | 136 | 2 | 22721696 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9722946 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 18508913 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 11719516 | ||
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 1.52e-05 | 2 | 136 | 2 | 28706277 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 21092585 | ||
| Interaction | UBC interactions | CCDC14 RABEP2 MYD88 USP34 UBR4 HECTD4 NVL RNF213 BRAP ITPR3 IKBKE ZNF451 USP4 HERC1 CAPN15 | 2.40e-07 | 446 | 132 | 15 | int:UBC |
| Interaction | UBE2L3 interactions | 1.31e-06 | 211 | 132 | 10 | int:UBE2L3 | |
| Interaction | UBE2D1 interactions | USP34 TRAF2 TRAF6 UVSSA MKRN2 TRIM24 ASB9 ZPR1 ARIH1 FBXL2 TRIM38 | 3.83e-06 | 294 | 132 | 11 | int:UBE2D1 |
| Interaction | ZIC2 interactions | 5.38e-06 | 39 | 132 | 5 | int:ZIC2 | |
| Interaction | NR3C1 interactions | RABEP2 TRAF2 PLVAP IPO7 KDM5A UBR4 RANBP9 PPFIA3 CMSS1 NCLN ARID1A INTS3 TRIM24 RYR1 ITPR3 CEP350 SMARCA2 SMARCA4 CEP295 STAG2 | 5.42e-06 | 974 | 132 | 20 | int:NR3C1 |
| Interaction | UBE2D2 interactions | TRAF2 TRAF6 UVSSA UBR4 MKRN2 HECTD4 RNF213 BRAP ZPR1 HERC1 TRIM38 | 8.07e-06 | 318 | 132 | 11 | int:UBE2D2 |
| Interaction | TOP3B interactions | USP34 POLG UBR4 MKRN2 RTTN HECTD4 LMNB2 NCLN ARID1A ZZEF1 LDLR RYR1 ITPR3 CELSR2 PLA2G4B IFRD2 LRRC56 STK40 HERC1 HAS3 SIPA1L2 PUM1 DNA2 ABTB2 ARAP1 | 8.98e-06 | 1470 | 132 | 25 | int:TOP3B |
| Interaction | IRF4 interactions | 2.02e-05 | 85 | 132 | 6 | int:IRF4 | |
| Interaction | RNF123 interactions | CFAP47 HSPBAP1 MYO19 UBR4 RNF213 PBX4 NCBP1 LMNB2 AGPS PPFIA3 PARP14 ZZEF1 RYR1 MTHFD1 CEP295 TNR FBXO34 | 2.77e-05 | 824 | 132 | 17 | int:RNF123 |
| Interaction | SPANXN3 interactions | 3.68e-05 | 29 | 132 | 4 | int:SPANXN3 | |
| Interaction | KDM1A interactions | CCDC14 USP34 KDM5A UBR4 MKRN2 RANBP9 MSANTD2 PBX4 TRIM24 KIF20B SPDL1 CEP350 RLF KRT39 ZNF451 BUB1 SMARCA2 ARIH1 | 4.27e-05 | 941 | 132 | 18 | int:KDM1A |
| Interaction | SMG7 interactions | 4.87e-05 | 319 | 132 | 10 | int:SMG7 | |
| Interaction | BRCA1 interactions | CFAP47 GNL3L IPO7 UBR4 MKRN2 RANBP9 PRC1 ARID1A TRIM24 KIF20B BRAP CEP350 BLM MTHFD1 SMARCA2 SMARCA4 ARIH1 POLN HERC1 HSPA14 CDK4 | 6.14e-05 | 1249 | 132 | 21 | int:BRCA1 |
| Interaction | NANOG interactions | USP34 GNL3L NVL PRC1 ARID1A TRIM24 KIF20B ITPR3 SMARCA2 SMARCA4 SIPA1L2 PUM1 | 7.80e-05 | 481 | 132 | 12 | int:NANOG |
| Interaction | PPP2R1B interactions | 8.61e-05 | 159 | 132 | 7 | int:PPP2R1B | |
| Interaction | SLX4 interactions | IPO7 PMPCB NVL TRIM24 SPDL1 CEP350 BLM MTHFD1 ZNF451 MCM9 SMARCA4 GID8 CORO7 | 9.98e-05 | 572 | 132 | 13 | int:SLX4 |
| Interaction | KDM4B interactions | 1.03e-04 | 71 | 132 | 5 | int:KDM4B | |
| Interaction | UBE2D3 interactions | 1.05e-04 | 283 | 132 | 9 | int:UBE2D3 | |
| Interaction | H2BC8 interactions | GNL3L POLG NVL NCBP1 PRC1 INTS3 TRIM24 KIF20B BLM RLF SMARCA4 STAG2 KDM4B | 1.07e-04 | 576 | 132 | 13 | int:H2BC8 |
| Interaction | PLEC interactions | USP53 TRAF2 MYO19 TSGA10 PRC1 SPDL1 KRT39 ZNF451 BUB1 USP4 DNA2 | 1.26e-04 | 430 | 132 | 11 | int:PLEC |
| Interaction | SH2D3C interactions | 1.41e-04 | 172 | 132 | 7 | int:SH2D3C | |
| Interaction | LMBR1L interactions | GNL3L IPO7 UBR4 LMNB2 CMSS1 NCLN PEX11B ITPR3 DNAAF5 IFRD1 LRIG1 CORO7 PUM1 HSPA14 STAG2 CAPN15 CDK4 | 1.51e-04 | 946 | 132 | 17 | int:LMBR1L |
| Cytoband | 3q21.1 | 2.79e-05 | 20 | 136 | 3 | 3q21.1 | |
| GeneFamily | Ring finger proteins | 4.76e-04 | 275 | 91 | 7 | 58 | |
| GeneFamily | TNF receptor associated factors | 5.18e-04 | 7 | 91 | 2 | 1056 | |
| Coexpression | FISCHER_DREAM_TARGETS | CCDC14 USP53 TCEA1 LRRC45 MYO19 RTTN NCBP1 CMSS1 PRC1 LDLR KIF20B SPDL1 BLM IFRD1 MTHFD1 IFRD2 BUB1 CEP295 DNA2 THAP12 CDK4 | 2.59e-08 | 969 | 135 | 21 | M149 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 IPO7 KDM5A NVL ZZEF1 TRIM24 LDLR KIF20B CEP350 BLM RLF IFRD1 LRIG1 ZNF451 SMARCA2 ARIH1 PUM1 STAG2 FBXW11 | 8.85e-08 | 856 | 135 | 19 | M4500 |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | TRAF2 ANXA3 UVSSA ARID1A INTS3 IFRD1 LRIG1 ARIH1 PUM1 STAG2 FBXW11 | 7.81e-07 | 316 | 135 | 11 | M2248 |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | TRAF2 ANXA3 UVSSA ARID1A INTS3 IFRD1 LRIG1 ARIH1 PUM1 STAG2 FBXW11 | 8.83e-07 | 320 | 135 | 11 | MM1063 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 9.99e-07 | 200 | 135 | 9 | M7532 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | CCDC14 RABEP2 TRAF2 LRRC45 MYO19 MKRN2 NVL NCBP1 LMNB2 AGPS CMSS1 PRC1 CCNQ KIF20B SPDL1 BLM METAP1 MTHFD1 IFRD2 BUB1 CEP295 DNA2 | 3.65e-06 | 1423 | 135 | 22 | M45722 |
| Coexpression | LIU_SOX4_TARGETS_DN | USP34 GNL3L HECTD4 ATP9B ITPR3 SMARCA2 SMARCA4 PUM1 STAG2 CAPN15 | 4.96e-06 | 310 | 135 | 10 | M17287 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CCDC14 TRAF2 LRRC45 MYO19 LMNB2 CMSS1 PRC1 LDLR KIF20B BRAP SPDL1 BLM MTHFD1 BUB1 SMARCA4 CEP295 DNA2 | 6.99e-06 | 939 | 135 | 17 | M45768 |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN | 9.67e-06 | 200 | 135 | 8 | M4533 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 9.67e-06 | 200 | 135 | 8 | M4531 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | CCDC14 TRAF2 LRRC45 RANBP9 LMNB2 PRC1 TRIM24 KIF20B SPDL1 BLM MTHFD1 BUB1 CEP295 DNA2 | 1.46e-05 | 694 | 135 | 14 | M45767 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | CCDC14 USP34 HSPBAP1 NCBP1 ERMP1 LMNB2 KIF20B BLM IFRD1 LRIG1 ZDHHC23 MCM9 SMARCA2 GID8 CEP295 HAS3 | 1.49e-05 | 892 | 135 | 16 | M18120 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | 1.99e-05 | 221 | 135 | 8 | M45789 | |
| Coexpression | DANG_BOUND_BY_MYC | KDM5A PMPCB NCBP1 AGPS PEX11B KIF20B BLM MTHFD1 ZPR1 ZNF451 IFRD2 BUB1 USP4 HERC1 THAP12 HSPA14 CDK4 | 3.34e-05 | 1061 | 135 | 17 | M15774 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | TCEA1 MYO1A POLG NCBP1 LMNB2 TRIM24 KIF20B BLM METAP1 BUB1 SMARCA4 DNA2 THAP12 CDK4 | 4.00e-05 | 761 | 135 | 14 | M11961 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 4.71e-05 | 323 | 135 | 9 | M2156 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | CCDC14 TRAF2 IPO7 LRRC45 NCBP1 LMNB2 AGPS CMSS1 PRC1 TRIM24 KIF20B SPDL1 BLM MTHFD1 IFRD2 BUB1 CEP295 DNA2 CDK4 | 7.35e-05 | 1363 | 135 | 19 | M45782 |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN | 7.98e-05 | 199 | 135 | 7 | M8960 | |
| Coexpression | GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN | 8.23e-05 | 200 | 135 | 7 | M7814 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP | 8.23e-05 | 200 | 135 | 7 | M3142 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CCDC14 MYO19 RNF213 NCBP1 LMNB2 CMSS1 PRC1 TRIM24 KIF20B BRAP SPDL1 IFRD1 ASB9 BUB1 SMARCA4 SIGLEC1 DNA2 HSPA14 CDK4 | 1.12e-04 | 1407 | 135 | 19 | M14427 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | TCEA1 IPO7 MYO19 MKRN2 RTTN RANBP9 NCBP1 PRC1 KIF20B SPDL1 ITPR3 BLM DNAAF5 IFRD1 MTHFD1 ZPR1 BUB1 DNA2 | 1.14e-04 | 1290 | 135 | 18 | M80 |
| Coexpression | NADERI_BREAST_CANCER_PROGNOSIS_UP | 1.39e-04 | 51 | 135 | 4 | M6862 | |
| Coexpression | BASAKI_YBX1_TARGETS_UP | 1.47e-04 | 294 | 135 | 8 | M14985 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TCEA1 ZBTB38 ZNF397 TRIM24 KIF20B SPDL1 CEP350 BLM RLF PIEZO2 SMARCA2 STAG2 | 1.54e-04 | 656 | 135 | 12 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.56e-04 | 466 | 135 | 10 | M13522 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | KDM5A PMPCB NCBP1 AGPS PEX11B TRIM24 KIF20B MTHFD1 ZPR1 USP4 HERC1 THAP12 HSPA14 | 1.90e-04 | 775 | 135 | 13 | M17753 |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.54e-09 | 193 | 136 | 9 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-08 | 180 | 136 | 8 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-08 | 180 | 136 | 8 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-08 | 180 | 136 | 8 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.19e-07 | 188 | 136 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-07 | 190 | 136 | 8 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.52e-07 | 194 | 136 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.92e-07 | 200 | 136 | 8 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.10e-06 | 174 | 136 | 7 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-06 | 178 | 136 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-06 | 185 | 136 | 7 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.07e-06 | 122 | 136 | 6 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.12e-06 | 192 | 136 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.19e-06 | 193 | 136 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 195 | 136 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 196 | 136 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.69e-06 | 199 | 136 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.24e-06 | 155 | 136 | 6 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.87e-06 | 157 | 136 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.10e-05 | 163 | 136 | 6 | 1a8c79903ed416f286ebe8a9922233affbc55d82 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 169 | 136 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 171 | 136 | 6 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 171 | 136 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 171 | 136 | 6 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.49e-05 | 172 | 136 | 6 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.64e-05 | 175 | 136 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 177 | 136 | 6 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 177 | 136 | 6 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 179 | 136 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.99e-05 | 181 | 136 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 2.05e-05 | 182 | 136 | 6 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 182 | 136 | 6 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 2.05e-05 | 182 | 136 | 6 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.25e-05 | 185 | 136 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 136 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 187 | 136 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-05 | 190 | 136 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.69e-05 | 191 | 136 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 192 | 136 | 6 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 192 | 136 | 6 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.85e-05 | 193 | 136 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 194 | 136 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 194 | 136 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 194 | 136 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 136 | 6 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 196 | 136 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 196 | 136 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 197 | 136 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 197 | 136 | 6 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 197 | 136 | 6 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 3.29e-05 | 198 | 136 | 6 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.39e-05 | 199 | 136 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.48e-05 | 200 | 136 | 6 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Cdc20)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.14e-05 | 131 | 136 | 5 | f9fb8d74ca720b81fd5910cc975510359a8ef751 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-05 | 142 | 136 | 5 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.17e-04 | 156 | 136 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 159 | 136 | 5 | ba82d1f55dd77c4b2183981b76cab1480fba75ad | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 165 | 136 | 5 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 167 | 136 | 5 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 168 | 136 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 168 | 136 | 5 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 168 | 136 | 5 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 169 | 136 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 136 | 5 | b535baeb4dbd644051cf992babb61add9eaae4e3 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 170 | 136 | 5 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 136 | 5 | 2477c9f29dbe27f172df699003971e828d6ab8c9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 172 | 136 | 5 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 172 | 136 | 5 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 173 | 136 | 5 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-04 | 173 | 136 | 5 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 173 | 136 | 5 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.90e-04 | 173 | 136 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.95e-04 | 174 | 136 | 5 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 174 | 136 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 174 | 136 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 174 | 136 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 174 | 136 | 5 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 174 | 136 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 174 | 136 | 5 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 174 | 136 | 5 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | Club-club-15|World / Class top | 2.01e-04 | 175 | 136 | 5 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-04 | 175 | 136 | 5 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-04 | 175 | 136 | 5 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-04 | 175 | 136 | 5 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 2.06e-04 | 176 | 136 | 5 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 176 | 136 | 5 | d6d7e4e937d49a5c0d16322c8dd3bf9e97eb8732 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 176 | 136 | 5 | c03d80df2550c0d2b0452326480d6bf21d20fdd2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 177 | 136 | 5 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 177 | 136 | 5 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 177 | 136 | 5 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 178 | 136 | 5 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-04 | 178 | 136 | 5 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 178 | 136 | 5 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.40e-06 | 180 | 136 | 9 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.53e-06 | 182 | 136 | 9 | 3887_DN | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 8.89e-07 | 5 | 133 | 3 | C3281201 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.15e-06 | 18 | 133 | 4 | EFO_0008317, EFO_0008589 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.45e-06 | 19 | 133 | 4 | EFO_0802076 | |
| Disease | large artery stroke, coronary artery disease | 4.64e-06 | 25 | 133 | 4 | EFO_0001645, EFO_0005524 | |
| Disease | Antithrombotic agent use measurement | 5.01e-06 | 55 | 133 | 5 | EFO_0009925 | |
| Disease | familial hyperlipidemia | 8.83e-06 | 106 | 133 | 6 | MONDO_0001336 | |
| Disease | Abnormal circulating lipid concentration | 2.02e-05 | 2 | 133 | 2 | HP_0003119 | |
| Disease | Coffin-Siris syndrome | 2.48e-05 | 13 | 133 | 3 | C0265338 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.49e-05 | 189 | 133 | 7 | EFO_0009932 | |
| Disease | aspirin use measurement | 2.87e-05 | 39 | 133 | 4 | EFO_0007013 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.14e-05 | 14 | 133 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 3.18e-05 | 40 | 133 | 4 | EFO_0004746 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 4.25e-05 | 43 | 133 | 4 | EFO_0022290 | |
| Disease | concentration of large LDL particles measurement | 4.66e-05 | 44 | 133 | 4 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 4.66e-05 | 44 | 133 | 4 | EFO_0022225 | |
| Disease | total lipids in very small VLDL measurement | 5.09e-05 | 45 | 133 | 4 | EFO_0022156 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.09e-05 | 45 | 133 | 4 | EFO_0022236 | |
| Disease | protocadherin alpha-4 measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0801972 | |
| Disease | Bloom syndrome (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:2717 (implicated_via_orthology) | |
| Disease | Abruptio Placentae | 6.03e-05 | 3 | 133 | 2 | C0000832 | |
| Disease | total lipids in small LDL | 6.05e-05 | 47 | 133 | 4 | EFO_0022168 | |
| Disease | free cholesterol in small VLDL measurement | 6.05e-05 | 47 | 133 | 4 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 6.05e-05 | 47 | 133 | 4 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 6.05e-05 | 47 | 133 | 4 | EFO_0022269 | |
| Disease | total lipids in lipoprotein particles measurement | 6.58e-05 | 48 | 133 | 4 | EFO_0022309 | |
| Disease | phospholipids in medium LDL measurement | 7.14e-05 | 49 | 133 | 4 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 7.14e-05 | 49 | 133 | 4 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 7.14e-05 | 49 | 133 | 4 | EFO_0022227 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 7.14e-05 | 49 | 133 | 4 | EFO_0022256 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 7.32e-05 | 224 | 133 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 7.74e-05 | 50 | 133 | 4 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 8.37e-05 | 51 | 133 | 4 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 8.37e-05 | 51 | 133 | 4 | EFO_0022300 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 8.37e-05 | 51 | 133 | 4 | EFO_0022242 | |
| Disease | parental longevity | HECTD4 LMNB2 LDLR BRAP CEP350 PTPRD CELSR2 SMARCA2 SMARCA4 CCDC171 | 8.50e-05 | 494 | 133 | 10 | EFO_0007796 |
| Disease | phospholipids in medium VLDL measurement | 9.03e-05 | 52 | 133 | 4 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 9.03e-05 | 52 | 133 | 4 | EFO_0022180 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 9.73e-05 | 53 | 133 | 4 | EFO_0022340 | |
| Disease | cholesterol in small VLDL measurement | 9.73e-05 | 53 | 133 | 4 | EFO_0022228 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.05e-04 | 54 | 133 | 4 | EFO_0022244 | |
| Disease | stroke, coronary artery disease | 1.12e-04 | 21 | 133 | 3 | EFO_0000712, EFO_0001645 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 1.12e-04 | 21 | 133 | 3 | EFO_0022246 | |
| Disease | Flushing | 1.20e-04 | 4 | 133 | 2 | HP_0031284 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.21e-04 | 56 | 133 | 4 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.21e-04 | 56 | 133 | 4 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.21e-04 | 56 | 133 | 4 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.29e-04 | 57 | 133 | 4 | EFO_0022284 | |
| Disease | low density lipoprotein particle size measurement | 1.39e-04 | 58 | 133 | 4 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.39e-04 | 58 | 133 | 4 | EFO_0022338 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.45e-04 | 335 | 133 | 8 | EFO_0009931 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.48e-04 | 59 | 133 | 4 | EFO_0022289 | |
| Disease | clinical and behavioural ideal cardiovascular health | 1.48e-04 | 23 | 133 | 3 | EFO_0007654 | |
| Disease | phospholipids in small VLDL measurement | 1.58e-04 | 60 | 133 | 4 | EFO_0022146 | |
| Disease | total lipids in VLDL measurement | 1.58e-04 | 60 | 133 | 4 | EFO_0022314 | |
| Disease | antihyperlipidemic drug use measurement | 1.78e-04 | 115 | 133 | 5 | EFO_0803367 | |
| Disease | triglycerides in medium LDL measurement | 1.80e-04 | 62 | 133 | 4 | EFO_0022322 | |
| Disease | free cholesterol in very large HDL measurement | 1.80e-04 | 62 | 133 | 4 | EFO_0022273 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.91e-04 | 63 | 133 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.91e-04 | 63 | 133 | 4 | EFO_0022239 | |
| Disease | myocardial infarction | 1.96e-04 | 350 | 133 | 8 | EFO_0000612 | |
| Disease | Werner syndrome (implicated_via_orthology) | 2.00e-04 | 5 | 133 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.01e-04 | 118 | 133 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | glycerol measurement | 2.16e-04 | 26 | 133 | 3 | EFO_0010115 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 2.16e-04 | 26 | 133 | 3 | OBA_2045194 | |
| Disease | Coronary Arteriosclerosis | 2.16e-04 | 65 | 133 | 4 | C0010054 | |
| Disease | cholesterol in large VLDL measurement | 2.16e-04 | 65 | 133 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.16e-04 | 65 | 133 | 4 | EFO_0022230 | |
| Disease | Coronary Artery Disease | 2.16e-04 | 65 | 133 | 4 | C1956346 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.17e-04 | 120 | 133 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | free cholesterol in large VLDL measurement | 2.57e-04 | 68 | 133 | 4 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.72e-04 | 69 | 133 | 4 | EFO_0022341 | |
| Disease | sphingomyelin measurement | 2.77e-04 | 278 | 133 | 7 | EFO_0010118 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 3.00e-04 | 29 | 133 | 3 | OBA_2045183 | |
| Disease | metabolic syndrome | 3.02e-04 | 200 | 133 | 6 | EFO_0000195 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.74e-04 | 75 | 133 | 4 | EFO_0022287 | |
| Disease | LDL cholesterol change measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0007804 | |
| Disease | catalase measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0008071 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.44e-04 | 215 | 133 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | carbohydrate intake measurement | 4.84e-04 | 34 | 133 | 3 | EFO_0010811 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.84e-04 | 34 | 133 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 5.01e-04 | 220 | 133 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | Kartagener Syndrome | 5.27e-04 | 35 | 133 | 3 | C0022521 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 5.27e-04 | 35 | 133 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 5.27e-04 | 35 | 133 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 5.27e-04 | 35 | 133 | 3 | C4317124 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 5.51e-04 | 224 | 133 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | progeria (implicated_via_orthology) | 5.55e-04 | 8 | 133 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | body weight | NPR3 ZBTB38 RTTN HECTD4 PPFIA3 ZZEF1 TRIM24 BRAP DGKK POLN DNA2 CCDC171 NOS3 KDM4B ARAP1 | 5.77e-04 | 1261 | 133 | 15 | EFO_0004338 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 6.18e-04 | 229 | 133 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 6.22e-04 | 37 | 133 | 3 | EFO_0022281 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.29e-04 | 86 | 133 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | liver fibrosis measurement | 6.29e-04 | 86 | 133 | 4 | EFO_0010576 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 7.11e-04 | 9 | 133 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | immunoglobulin M measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0020466 | |
| Disease | Paroxysmal atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C2585653 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 7.27e-04 | 39 | 133 | 3 | EFO_0022332 | |
| Disease | lipid measurement, lipoprotein measurement | 7.47e-04 | 90 | 133 | 4 | EFO_0004529, EFO_0004732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSLKEDVRRSAMLCI | 151 | Q7Z569 | |
| VARTASEELACLLMD | 206 | Q96DX5 | |
| CDKESNMERRVITIS | 201 | O43683 | |
| LVDTLCMETQERDVR | 716 | Q9NQ75 | |
| ALVERRDTLRLMCSS | 141 | Q2WEN9 | |
| MDCSDLLRRQTSELE | 246 | Q6TFL3 | |
| AVDCMSRELVSLTSR | 431 | Q9NWN3 | |
| LVERDRATLAALETM | 106 | P47895 | |
| GCSSSEILRMERIIL | 121 | Q14094 | |
| MVSRSEIDLLDIRTE | 276 | P12429 | |
| EESRLVAEMLCTATA | 976 | Q8IYW2 | |
| MITDLEARCLSLRVR | 1726 | Q8IYW2 | |
| ICSSAVRALELIRSM | 161 | Q9BQ75 | |
| KTAEDRRMSDLTCVL | 21 | Q8WTQ4 | |
| SALHLVRECSTEMAR | 2411 | Q86UQ4 | |
| VRECSTEMARLLDTI | 2416 | Q86UQ4 | |
| IMREDCTTIEVLLRN | 36 | A6NGH8 | |
| AQCALRVTIITDEML | 1111 | Q9HCU4 | |
| ELRDSIVQCELLMLR | 116 | Q8N1B3 | |
| SEIQRLITEMEACIS | 451 | Q49A88 | |
| SDDAVSCSVMLEVLR | 216 | Q7Z2K6 | |
| DNTVVMEEIRRLCRT | 171 | Q9Y4P1 | |
| RVVIMCASSDTIRSI | 256 | P17342 | |
| ECAALVRRTMESLEQ | 816 | Q7Z5Q5 | |
| CMEVILEKASASERR | 241 | Q9H000 | |
| LEITISEARCLELHM | 376 | Q6P1R3 | |
| TEMEVDSSQLRRQLC | 596 | Q96S59 | |
| VLEASLCSLRTEMER | 476 | Q9H5N1 | |
| DELEERLERCMSIVT | 46 | Q68E01 | |
| ERRIVAQLLTCMDDL | 381 | O15381 | |
| RELDSTERACDTLLM | 2446 | Q14573 | |
| EARTMAAEVLSRRCV | 71 | Q969V3 | |
| DLVERVMVTRSLCAE | 566 | O75808 | |
| DCLEMLRENTLVTLA | 2051 | O14497 | |
| CDILVDDNTVMRLIT | 236 | Q9Y4X5 | |
| MRLCTSVTESEVARA | 386 | O75439 | |
| MDLEECILITDSTLI | 291 | Q9UKC9 | |
| TEMIIATRFLCSAVE | 666 | Q5KSL6 | |
| QVVDLLVSMCRSALE | 556 | Q8N3A8 | |
| LSSEDIEGMRLVCRL | 131 | P53582 | |
| VSREELMTVLSRLAD | 1601 | Q16787 | |
| HDITIRTTTMARLEC | 606 | Q96JA1 | |
| RFIMILTEHLVRCET | 716 | Q09161 | |
| RMRDSQECILTETEA | 331 | Q6A163 | |
| TDSMLELLECGRARV | 746 | Q96H55 | |
| EEVERALCSRTMETA | 311 | Q9UBC5 | |
| ETLMRVDLENRCQSL | 201 | Q03252 | |
| ECLVSRHERSLRMTV | 121 | O75145 | |
| ATLTRELSMCREQLL | 81 | O75335 | |
| ESLEREMELLCLTGV | 726 | O43861 | |
| TDIRTLVRLMCLAAA | 3216 | Q15751 | |
| VMEVLQATCRRTLEV | 446 | Q14164 | |
| AVMSCEVLRVLQLSD | 321 | P57737 | |
| RMELAIRNSALDTCI | 376 | Q9BX97 | |
| REVKTSELRTMCLQV | 771 | O95373 | |
| DMASATDITLRRVLV | 346 | Q9UKB1 | |
| EMSRVIRVSELSLCD | 366 | Q96Q89 | |
| SAVDIDRCLRKEVTM | 1181 | P54098 | |
| IGSLRTILDMVEREC | 151 | O94953 | |
| SIASELIEKRCRRMV | 206 | Q99836 | |
| RETLCTELVLSDCML | 56 | Q96CN5 | |
| MAVAEVSRTCLLTVR | 1 | P0C869 | |
| RTRACLVMAQLLEDS | 1861 | Q9Y4D8 | |
| MAALSCLLDSVRRDI | 1 | Q14990 | |
| CKELTLMTEEETRLR | 636 | P29375 | |
| LEDVAVCMDLDTRTT | 376 | P29474 | |
| RTERAVLIDEVCTMN | 1091 | Q14671 | |
| RQMLEICESCIREET | 236 | O43422 | |
| CMTSATIDVTTVERL | 736 | Q9H158 | |
| STSSLKIMEDIIREC | 1101 | Q460N5 | |
| IIRECMEITESLSLK | 1111 | Q460N5 | |
| TCEAVMTLRSRLLDA | 196 | Q9BYU1 | |
| EMRCTIRLLDDSEIS | 31 | A2A2Y4 | |
| EVINVCSDLRMLDSL | 1286 | Q9P2D7 | |
| ARVEEAITRMLVCAL | 281 | Q96EW2 | |
| LSRRECDTMADTLQR | 896 | P54132 | |
| VVRLMDVCATSRTDR | 71 | P11802 | |
| RDCRAALAEITEMVA | 711 | Q9Y4F1 | |
| SRECLTEMERTLALL | 136 | Q9NWU2 | |
| TARLTTDAARQICEM | 1441 | Q5VT06 | |
| TDAARQICEMAELTR | 1446 | Q5VT06 | |
| ERRMTLTDSIERCLK | 121 | O00458 | |
| DMEALCSVLRTLATD | 366 | Q12894 | |
| MDRVRDVVRASTFSC | 171 | O00219 | |
| VRDCITESSLRSDMC | 941 | Q5M9N0 | |
| EEDSKMTRLISCRII | 711 | Q86Y56 | |
| VEETDSRLCVRTVEM | 2316 | Q9C0D2 | |
| ASSIRCMRRAVLSET | 131 | P51530 | |
| EIRLLMEQESSACSR | 141 | O96011 | |
| TDRRVLLMFLDICSE | 61 | Q96E40 | |
| CMDILELSERLDLQR | 1646 | P21817 | |
| IELLSMSSDRRLECI | 241 | Q6ZTR5 | |
| AVLALTTSLEDMRER | 571 | P11586 | |
| VVERTRTATMLCAAS | 136 | P23468 | |
| VEDSLMIECSARDIL | 386 | Q0VDF9 | |
| DVIMDRSTCVQRATV | 131 | Q8NHC5 | |
| RLMFRDTVTLEDAIT | 581 | Q9NXL9 | |
| ILLDQSECSMVRREA | 1421 | Q86VV8 | |
| EDRCTEQKLSTAMRI | 151 | O00635 | |
| VRCLRTRTRMDEEVS | 441 | Q2YD98 | |
| RTCEIVEDTESSRMV | 116 | Q8N2I9 | |
| VVACMRRDTTLETAL | 396 | P51531 | |
| DDLRLVRTLEMCVDT | 66 | Q8IYG6 | |
| VRTLEMCVDTREGSL | 71 | Q8IYG6 | |
| SNSMVDVCSVDRRSV | 511 | Q9NVN8 | |
| MRRSEVLAEESIVCL | 1 | O43663 | |
| VVCMRRDTALETALN | 421 | P51532 | |
| LSCKSEELRVMSERV | 141 | Q96EA4 | |
| IVTRGCETVEMTLRR | 941 | Q9P2F8 | |
| TSDSVRLKCREMLAA | 136 | P23193 | |
| LTACMENLVEEIRAR | 231 | Q8N961 | |
| MCPADETRTIISLDT | 246 | O00116 | |
| SMTAEELTLEILDRR | 1196 | Q96P48 | |
| DVLHASVRRSTIVCM | 191 | Q96M20 | |
| SVRRSTIVCMEETEF | 196 | Q96M20 | |
| DSTNRDSLDMIERCI | 371 | P28329 | |
| VEESLIDMRDLCSLL | 711 | P28329 | |
| TTALCNEVERMLERH | 186 | Q70EK8 | |
| REVERVAMTAEACSR | 291 | Q12933 | |
| SAEIVCRMIRLLSLV | 871 | Q63HN8 | |
| VRIDRICSLMAVENE | 221 | Q8IWX7 | |
| VCDDSGVIRLHMSRI | 506 | Q9Y4E5 | |
| MTRDLLKSETCSVEI | 321 | O75312 | |
| DIDCSSTIMLDNIVR | 626 | O15164 | |
| VALRDCIELFTTMET | 776 | Q13107 | |
| CVRALQLRSSEDEEM | 376 | Q13129 | |
| RQESALIEIMLCTIR | 516 | Q8N3U4 | |
| LMEVTDSLDRCIQRL | 286 | Q96N76 | |
| ACSLESRDVVLELMS | 1281 | A6NE52 | |
| DTLLVRCEVSTRFDM | 491 | Q9Y4K3 | |
| IEMLEREVSVLRDQC | 141 | Q92752 | |
| DISTVLRIERCMLTR | 1676 | Q9H5I5 | |
| DSRARSMAVIQCTVD | 1356 | Q9BZZ2 | |
| EDMVSSERTCTLAII | 151 | Q86XW9 | |
| CERIMDTISDRLRIP | 66 | Q8IYP9 | |
| TEALIVCEQDVSRMR | 316 | Q9BZW7 | |
| EAERCLILTTDSIMC | 261 | Q8NF99 | |
| LVSVAARECELLMLS | 936 | O43149 | |
| KVSDSMRTASLCLER | 191 | Q8NAP3 | |
| DSCISDMKTETREVL | 3366 | Q70CQ2 | |
| QRTTMILLCEDGSLR | 2226 | Q5T4S7 | |
| LRSSCMVVRVDDLDI | 461 | Q6BDS2 | |
| SREDLLMRLLECDVI | 101 | Q96M32 | |
| RDMRSCLTEAEAAVA | 706 | P01130 |